Dermatologic therapy

Keyphrases

Publications

volume 35, number 9, 2022

Paul Gressenberger, Daisy Kopera
Bimatoprost for the treatment of female androgenetic alopecia-A case report. Dermatologic therapy 35 (9) (2022)
Leonardo Bianchi, Katharina Hansel, Filippo Biondi, Maddalena Napolitano, Cataldo Patruno, Gabriella Fabbrocini, Luca Penchini, Luca Stingeni
Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series. Dermatologic therapy 35 (9) (2022)
Fahimeh Abdollahimajd, Mohammad Reza Pourani, Hamid Mahdavi, Hamid Mirzadeh, Shima Younespour, Hamideh Moravvej Farshi
Efficacy and safety of chitosan-based bio-compatible dressing versus nanosilver (Acticoat TM ) dressing in treatment of recalcitrant diabetic wounds: A randomized clinical trial. Dermatologic therapy 35 (9) (2022)
Alireza Khatami, Taraneh Yazdanparast, Saman Ahmad Nasrollahi, Akram Miramin Mohammadi, Somayeh Yadangi, Ali Khamesipour, Martin Kassir, Alireza Firooz
Biophysical and ultrasonographic changes of acute Old World cutaneous leishmaniasis skin lesions in comparison with uninvolved skin: A possible tool for non-invasive early detection and treatment outcome assessment. Dermatologic therapy 35 (9) (2022)
Marina Vastarella, Fabrizio Martora, Sonia Sofia Ocampo-Garza, Angela Patrì, Teresa Battista, Paola Nappa, Gabriella Fabbrocini, Mariateresa Cantelli
Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors. Dermatologic therapy 35 (9) (2022)
Dalia Mahmoud Toma, Rabie Bedir Atallah, Ramadan Mohamed Eldahshan
Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata. Dermatologic therapy 35 (9) (2022)
Chaima Kouki, Amouri Mariem, Linda Manaa, Kammoun Nadine, Bahloul Emna, Sellami Khadija, Boudaya Sonia, Masmoudi Abderrahman, Turki Hamida
Salt in umbilical granuloma, it takes 1 day to take it all off: Report of two cases. Dermatologic therapy 35 (9) (2022)
Gulsun Hazan Tabak, Neslihan Akdogan, Beril Yel, Ozay Gokoz
The emergence of morphea in a patient undergoing ustekinumab therapy given for psoriasis. Dermatologic therapy 35 (9) (2022)
Shaimaa Farouk, Wafaa Afifi, Hala S A Hafiz, Hala M Maghraby
Split body comparative clinical and radiological study of fractional CO 2 laser versus carboxytherapy in treatment of striae distensae. Dermatologic therapy 35 (9) (2022)
James Coe, Shobha Kudva, Kave Shams
Matching the dose to the disease: Successful treatment of recalcitrant pyoderma gangrenosum using high-dose secukinumab. Dermatologic therapy 35 (9) (2022)
Tugba Erat, İsa An
Treatment of pediatric cutaneous leishmaniasis with liposomal amphotericin B. Dermatologic therapy 35 (9) (2022)
Sinu Rose Mathachan, Kabir Sardana, Ananta Khurana
A study examining the combination of methotrexate and leflunomide with topical anthralin in pediatric alopecia areata-a possible steroid-free regimen with diverse mechanistic actions. Dermatologic therapy 35 (9) (2022)
Julia Montero-Menárguez, Christian Gutiérrez-Collar, Mario Puerta Peña, Keila Mitsunaga, José Luis Rodríguez Peralto, Virginia Velasco-Tamariz
Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings. Dermatologic therapy 35 (9) (2022)
Maddalena Napolitano, Teresa Battista, Fabrizio Martora, Davide Fattore, Gabriella Fabbrocini, Cataldo Patruno
An uncommon case of lichen spinulosus induced by dupilumab in a patient treated for bronchial asthma. Dermatologic therapy 35 (9) (2022)
Bela J Shah, Deval Mistry, Shikha R Shah
Long-term efficacy and safety analysis of single cycle of biosimilar rituximab in pemphigus: A retrospective study of 76 patients from India. Dermatologic therapy 35 (9) (2022)
Maria L Musumeci, Maria R Nasca, Simona Boscaglia, Giuseppe Micali
The role of lifestyle and nutrition in psoriasis: Current status of knowledge and interventions. Dermatologic therapy 35 (9) (2022)
Chieh-Hsun Chen, Yang-Yi Chen, Cheng-Che E Lan
Intractable alopecia areata following the second dose of COVID-19 vaccination: Report of two cases. Dermatologic therapy 35 (9) (2022)
Alessandro Laghi, Chiara Franceschini, Victor Desmond Mandel, Miriam Teoli, Felice Musicco, Massimo Sansone, Antonia Marina La Malfa, Marco Ardigò
Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature. Dermatologic therapy 35 (9) (2022)
Yu Jie Zhang, Yang Mei Chen, Xin Yi Shao, Lin Liu, Yi Huan Pu, Lin Zhao Zhang, Jia Yi Chen, Jin Chen
Combination treatment with 30% salicylic acid and fractional CO 2 laser for acne scars: A 20-week prospective, randomized, split-face study. Dermatologic therapy 35 (9) (2022)
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, Rana Samii, Zeinab Farimani, Pedram Molhem Azar, Kamran Balighi, Robabeh Abedini, Tahereh Soori, Ali Salehi Farid, Hamid Reza Mahmoudi, Maryam Danespazhooh
Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study. Dermatologic therapy 35 (9) (2022)
Francesco Bellinato, Maria Gaia Mastrosimini, Giulia Querzoli, Paolo Gisondi, Giampiero Girolomoni
Dupilumab for recalcitrant Kimura disease. Dermatologic therapy 35 (9) (2022)
Matteo Megna, Luca Potestio, Elisa Camela, Gabriella Fabbrocini, Ruggiero Angelo
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting. Dermatologic therapy 35 (9) (2022)
Maria Relvas, Ana Carolina Figueiredo, Rebeca Calado, Joana Cruz Matos Calvão da Silva, Leonor Ramos
Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases. Dermatologic therapy 35 (9) (2022)
Ying Huang, Lin Zhu, Xiaoying Ma, Yiyong Hong, Xiangyang Su, Wei Lai, Zijian Gong
A case of sintilimab-induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein-1 inhibitors. Dermatologic therapy 35 (9) (2022)
Maria Bracho-Borro, Paulina Ailed Franco-Ruiz, Mario Magaña
The use of azathioprine in atopic dermatitis: A review. Dermatologic therapy 35 (9) (2022)
Andrea Sechi, Annalisa Patrizi, Beatrice Raone
Intralesional steroid injections to target sinus tract fibrosis in hidradenitis suppurativa: Results from an ultrasound-based retrospective study. Dermatologic therapy 35 (9) (2022)
Huiying Wan, Haiping Jia, Tian Xia, Dingding Zhang
Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis. Dermatologic therapy 35 (9) (2022)
Michela Iannone, Agata Janowska, Valentina Dini
Management of scarring HS fistulas with intralesional steroids. Dermatologic therapy 35 (9) (2022)
Aslan Yurekli, Ayşenur Botsali
Can we increase the success of scabies treatment? The effect of removing tunnels from patients in the success of scabies treatment. Dermatologic therapy 35 (9) (2022)
Javier Antoñanzas, Nuria Rodríguez-Garijo, Ángela Estenaga, Ana Morello-Vicente, Agustín España, Leyre Aguado
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review. Dermatologic therapy 35 (9) (2022)
Noelia Moreiras Arias, Cecilia Buján-Bonino, Patricia Pérez Feal, María López-Pardo Rico, Jose Manuel Suaréz-Peñaranda, Igor Vázquez Osorio
Lupus-like reaction following imiquimod treatment for actinic keratoses. Dermatologic therapy 35 (9) (2022)
Shaimaa Farouk, Ghada Raslan, Monira El Waseef
Psoriasis with Sputnik V vaccine, a potential triggering factor. Dermatologic therapy 35 (9) (2022)
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto, Pietro Quaglino, Simone Ribero
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? Dermatologic therapy 35 (9) (2022)
Alen Zabotti, Ivan Giovannini, Salvatore De Vita, Giuseppe Stinco, Enzo Errichetti
Recalcitrant and persistent adalimumab-induced paradoxical psoriasiform skin reaction in a rheumatoid arthritis patient successfully treated with upadacitinib. Dermatologic therapy 35 (9) (2022)
Terri Shih, Katrina Lee, Tristan Grogan, Devea R De, Vivian Y Shi, Jennifer L Hsiao
Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis. Dermatologic therapy 35 (9) (2022)
Ansieh Samadi, Yasaman Ketabi, Rojin Firooz, Alireza Firooz
Efficacy of intramuscular injections of biotin and dexpanthenol in the treatment of diffuse hair loss: A randomized, double-blind controlled study comparing two brands. Dermatologic therapy 35 (9) (2022)
Zhenkai Zhao, Xiaoning Zhang, Rui Wang, Youlin Wang, Lingling Gong, Chengxin Li
Vaccine-induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatologic therapy 35 (9) (2022)
Kajal Patel, Claire Higgins, Nishan Amerasinghe, Robert Kelly
Erthyema nodosum migrans-Successful treatment with colchicine. Dermatologic therapy 35 (9) (2022)
Catarina Correia, Joana Antunes, Paulo Filipe
Management of acne induced by JAK inhibitors. Dermatologic therapy 35 (9) (2022)
Hossam M Abdel-Wahab, Amira K Ali, Maha Hussain Ragaie
Calcipotriol: A novel tool in treatment of acne vulgaris. Dermatologic therapy 35 (9) (2022)
Giuseppe Lodi, Gaia Fasano, Steven Paul Nisticò, Luigi Bennaro, Giovanni Cannarozzo, Mario Sannino
Five hundred and thirty-two-nanometer Q-switched Nd:Yag laser with larger fractional spot: A novel and safe technique to treat Café au lait macule-A case report. Dermatologic therapy 35 (9) (2022)
Mingqin Su, Hongjie Liu, Yu-Ping Ran
Successfully treated extragenital lichen sclerosus in a 2-year-old boy by baricitinib assessed by dermoscopy: A case report. Dermatologic therapy 35 (9) (2022)
Shirley Braga Lima Gamonal, Nathália Couri Vieira Marques, Heitor Motta Bini Pereira, Aloisio Carlos Couri Gamonal
New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2. Dermatologic therapy 35 (9) (2022)
Tomasz Krzysztofiak, Grażyna Kamińska-Winciorek, Aleksandra Pilśniak, Piotr Wojcieszek
High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review. Dermatologic therapy 35 (9) (2022)
Bi-Cheng Wang, Bo-Ya Xiao, Bo-Hua Kuang, Guo-He Lin
The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies. Dermatologic therapy 35 (9) (2022)
Shekhar Neema, Senkadhir Vendhan, Biju Vasudevan, Ahmed Wahid Kashif, Rahul Thombre
Rituximab-induced new onset palmo-plantar pustulosis in patients with pemphigus foliaceus: A rare adverse effect. Dermatologic therapy 35 (9) (2022)
Matteo Megna, Alessia Villani, Luca Potestio, Elisa Camela, Gabriella Fabbrocini, Sonia Sofia Ocampo-Garza
Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation. Dermatologic therapy 35 (9) (2022)
Liangjiao Dong, Qian Li, Yihui Yu, Jingyao Liang, Xibao Zhang
Efficacy of adalimumab in the treatment of refractory livedoid vasculopathy: Case report and literature review. Dermatologic therapy 35 (9) (2022)
Iman Mohamed Abdelmeniem, Iman Mohamed El Eryan, Ahmad Nofal, Ibrahim Fouda, Salma Samir Omar
Topical calcipotriol combined with urea 20% versus intralesional injection of triamcinolone acetonide, 5-fluorouracil, and methotrexate in the treatment of nail psoriasis: A comparative study. Dermatologic therapy 35 (9) (2022)
Ozge Sevil Karstarli Bakay, Nida Kacar
Combined treatment with omalizumab and secukinumab in a patient with chronic spontaneous urticaria and psoriasis. Dermatologic therapy 35 (9) (2022)